Implantable cardioverter defibrillators (ICDs) were found to have a beneficial effect on mortality in patients with chronic kidney disease (CKD). Mortality in patients with chronic kidney disease (CKD ...

Please provide your email address to receive an email when new articles are posted on . Patients with HF and CAD who increased their daily levels of physical activity after receiving an implantable ...

Among patients with advanced HFrEF, women, compared with men, are less likely to receive an implantable cardiac defibrillator. Women who have advanced heart failure with reduced ejection fraction ...

Please provide your email address to receive an email when new articles are posted on . Patients with scar-related ventricular tachycardia (VT) who received VT ablation plus a subcutaneous ICD had ...

The purpose of this paper is to describe how a selected group of United States patients with an implantable cardioverter-defibrillator perceived their life situation. A qualitative design based on the ...

In a new publication from Cardiovascular Innovations and Applications; Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, ...

PROFID EHRA, the first clinical trial seeking to challenge routine implantation of defibrillators in heart attack survivors with heart failure has just been launched. The European Society of ...

PARIS, France—Early use of an implantable cardioverter-defibrillator (ICD) following PCI in patients at high risk of death is associated with a reduction in mortality over the long term, according to ...

Boston Scientific Shockless Implant Evaluation (SIMPLE) Study Results Presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions The trial results demonstrated that ...

Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention lengthens survival in patients at high risk of death after ST-segment elevation myocardial infarction ...